Covid-19
Showing NaN - NaN of 84
COVID-19 Trial in United States (Vaccine Messaging, Vaccine Acceptance Question)
Not yet recruiting
- COVID-19
- Vaccine Messaging
- Vaccine Acceptance Question
-
San Francisco, California
- +6 more
Dec 1, 2023
COVID-19 Trial in Houston (COVID-19 Group Problem Solving, Standard of Care, Booster session)
Recruiting
- COVID-19
- COVID-19 Group Problem Solving
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Nov 22, 2023
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
Bioaerosol Sampling Device (BSD) Clinical Study
Recruiting
- COVID-19
-
S. Gate, California
- +5 more
Sep 14, 2023
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2 (Omi XBB.1.5)
-
Dublin, California
- +14 more
Aug 10, 2023
COVID-19, Proning, Oxygenation Trial in Houston (Proning group, Control group)
Completed
- COVID-19
- +3 more
- Proning group
- Control group
-
Houston, TexasBaylor St. Luke's Medical Center
Jul 21, 2023
COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)
Recruiting
- COVID-19
- mRNA-1283.222
- mRNA-1273.222
-
Birmingham, Alabama
- +209 more
Apr 13, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)
Recruiting
- Influenza, Human
- COVID-19
- bivalent BNT162b2 (original/Omi BA.4/BA.5)
- +2 more
-
Athens, Alabama
- +18 more
Dec 22, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
-
Anaheim, California
- +20 more
Nov 30, 2022
Sars-CoV2, Acute Respiratory Distress Syndrome, COVID-19 Trial in Houston (Mesenchymal Stromal Cells, Supportive Care)
Recruiting
- Sars-CoV2
- +2 more
- Mesenchymal Stromal Cells
- Supportive Care
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
COVID-19 Trial in Worldwide (AZD7442, Placebo)
COVID-19 Trial in Worldwide (Sotrovimab)
Recruiting
- COVID-19
- Sotrovimab
-
Cullman, Alabama
- +17 more
Nov 4, 2022
COVID-19 Trial in Brownsville, Houston, Tyler (Facilitated Self-Sampling Intervention (FSSI), Testing Navigation Intervention
Not yet recruiting
- COVID-19
- Facilitated Self-Sampling Intervention (FSSI)
- +2 more
-
Brownsville, Texas
- +2 more
Nov 3, 2022